Givastomig, a CLDN18.2 x 4-1BB bispecific antibody, continues to show robust efficacy when combined with nivolumab and ...

A recent study published in the medical journal Gut has revealed a novel cancer-promoting mechanism of Streptococcus ...

Gastric (stomach) cancer remains one of the most common and deadly cancers in East Asia, including Korea. Yet despite its ...

Precision oncology advancements have led to new treatment options for gastric cancer, including immunotherapy and targeted ...

Gastric cancer cells can activate KRAS-driven signals, enabling autonomous tumor growth by producing their own WNT proteins. New research reveals how gastric cancer cells exploit WNT signaling for ...

NovaBridge Biosciences ( ($NBP) ) just unveiled an update. On January 6, 2026, NovaBridge Biosciences reported updated Phase 1b data showing that ...

SNB-101 previously received ODDs from the US FDA for small cell lung cancer in July 2023 and pancreatic cancer in February 2024. By receiving an ODD for gastric cancer this time, SN Bioscience expects ...

Investing.com -- NovaBridge Biosciences (NASDAQ:NBP) stock surged 19% in premarket trading Tuesday after the company reported positive data for its experimental gastric cancer treatment.

One of the areas that stomach cancer patients are worried about is the function of the stomach responsible for 'the pleasure ...